- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Vanderbilt-Ingram Cancer Center
Total 1407 results
-
Vanderbilt-Ingram Cancer CenterRecruitingSoft Tissue SarcomasUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingHematopoietic Cell TransplantationUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingEstrogen Receptor-positive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingPolycythemia Vera | MyelofibrosisUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMalignant GliomaUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedMalignant NeoplasmUnited States
-
Vanderbilt-Ingram Cancer CenterTerminated
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
Vanderbilt-Ingram Cancer CenterCompletedAdult Stem Cell Hematopoetic TransplantUnited States
-
Vanderbilt-Ingram Cancer CenterRecruitingMetastatic Digestive System Neuroendocrine Neoplasm | Metastatic Malignant Neoplasm in the Liver | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Digestive System Neuroendocrine Tumor G1 | Digestive System Neuroendocrine Tumor G2United States
-
Vanderbilt-Ingram Cancer CenterRecruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Refractory MelanomaUnited States
-
Vanderbilt-Ingram Cancer CenterRecruitingDiabetes Mellitus | CancerUnited States
-
Vanderbilt-Ingram Cancer CenterRecruiting
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingCOVID-19 | Invasive Malignancy (Any Type)United States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Vanderbilt-Ingram Cancer CenterTerminatedEndocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerHormone-sensitive Metastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNot yet recruiting
-
Vanderbilt-Ingram Cancer CenterTerminatedThyroid Carcinoma | Radioactive Iodine LevelUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingSickle Cell Disease | HemoglobinopathiesUnited States, United Kingdom, France
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Vanderbilt-Ingram Cancer CenterWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer
-
Vanderbilt-Ingram Cancer CenterCompletedRectal CancerUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedRecurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Vanderbilt-Ingram Cancer CenterMedtronicActive, not recruiting
-
Vanderbilt University Medical CenterVanderbilt-Ingram Cancer CenterCompletedCancer | Chronic Pain | Chronic Disease | Cancer Head Neck | Chronic Inflammation | Neuroinflammatory ResponseUnited States
-
Natalie LockneyRecruitingHead and Neck Cancer | Locally Advanced Head and Neck CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNovoCure Ltd.TerminatedExtensive Stage Small Cell Lung CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.RecruitingStage IV Lung Cancer | Extensive Stage Lung Small Cell CarcinomaUnited States
-
Cody StanselActive, not recruitingCancer | ChemotherapyUnited States
-
Bethany RhotenActive, not recruiting
-
Michael TopfRecruitingHead and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and NeckUnited States
-
Joshua LawrenzRecruiting
-
Vanderbilt-Ingram Cancer CenterCumberland PharmaceuticalsActive, not recruitingMalignant Solid TumorUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingPulmonary NoduleUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterAmerican Cancer Society, Inc.RecruitingHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8United States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingCancer Survivor | Retinoblastoma | Unilateral Retinoblastoma | Intraocular Retinoblastoma | Biological SiblingUnited States, Canada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Stage I Mycosis Fungoides | Stage II Mycosis Fungoides | Stage III Mycosis FungoidesUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingLung CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Hyperparathyroidism | Parathyroid Neoplasms | Hypercalcemia | Parathyroid Adenoma | Parathyroid Cancer | Parathyroid HyperplasiaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedHead and Neck CancerUnited States